Prospera Financial Services Inc Bristol Myers Squibb CO Transaction History

Prospera Financial Services Inc

$3.5 Billion
Q2 2024

A detailed history of Prospera Financial Services Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prospera Financial Services Inc holds 52,339 shares of BMY stock, worth $2.78 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

52,339

Previous 28,164 85.84%

Holding current value

$2.78 Million

Previous $1.45 Million 50.38%

% of portfolio

0.06%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $973,043 - $1.28 Million	24,175 Added 85.84%	52,339 $2.17 Million
Q1 2024 Aug 13, 2024	SELL	$47.98 - $54.4 $560,982 - $636,044	-11,692 Reduced 22.34%	40,647 $2.2 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $160,905 - $192,004	-3,319 Reduced 10.54%	28,164 $1.45 Million
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $237,349 - $265,393	4,100 Added 14.97%	31,483 $1.83 Million
Q2 2023 Aug 08, 2023	BUY	$63.71 - $70.74 $46,572 - $51,710	731 Added 2.74%	27,383 $1.75 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $10,710 - $12,148	-163 Reduced 0.61%	26,652 $1.85 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $31,500 - $37,301	-460 Reduced 1.69%	26,815 $1.93 Million
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $149 - $88,135	1,147 Added 4.39%	27,275 $1.94 Million
Q2 2022 Aug 08, 2022	BUY	$72.62 - $79.98 $235,724 - $259,615	3,246 Added 14.19%	26,128 $2.01 Million
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $22,255 - $26,686	362 Added 1.61%	22,882 $1.67 Million
Q4 2021 Feb 10, 2022	BUY	$53.63 - $62.52 $316,577 - $369,055	5,903 Added 35.52%	22,520 $1.41 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $417,030 - $488,496	-7,048 Reduced 29.78%	16,617 $984,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $296,177 - $322,537	4,784 Added 25.34%	23,665 $1.58 Million
Q1 2021 May 06, 2021	SELL	$59.34 - $66.74 $154,105 - $173,323	-2,597 Reduced 12.09%	18,881 $1.19 Million
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $501,471 - $568,259	8,685 Added 67.89%	21,478 $1.33 Million
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $172,979 - $191,683	-3,012 Reduced 19.06%	12,793 $771,000
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $20,667 - $24,161	377 Added 2.44%	15,805 $929,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $286,288 - $416,043	-6,170 Reduced 28.57%	15,428 $860,000
Q4 2019 Feb 12, 2020	BUY	$49.21 - $64.19 $492,493 - $642,413	10,008 Added 86.35%	21,598 $1.39 Million
Q3 2019 Oct 22, 2019	BUY	$42.77 - $50.71 $30,708 - $36,409	718 Added 6.6%	11,590 $588,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $1.79 Million - $1.98 Million	40,057 New	40,057 $2.06 Million
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $1.3 Million - $1.44 Million	-29,185 Reduced 72.86%	10,872 $495,000
Q1 2019 May 02, 2019	SELL	$45.12 - $53.8 $1.81 Million - $2.16 Million	-40,057 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $134,138 - $173,945	-2,751 Reduced 6.43%	40,057 $2.06 Million
Q3 2018 Oct 25, 2018	SELL	$55.19 - $62.25 $348,855 - $393,482	-6,321 Reduced 12.87%	42,808 $2.58 Million
Q2 2018 Jul 18, 2018	SELL	$50.53 - $62.98 $1,768 - $2,204	-35 Reduced 0.07%	49,129 $2.73 Million
Q1 2018 Apr 12, 2018	SELL	$59.92 - $68.98 $131,584 - $151,480	-2,196 Reduced 4.28%	49,164 $3.1 Million
Q4 2017 Jan 24, 2018	SELL	$59.94 - $65.35 $777,182 - $847,328	-12,966 Reduced 20.16%	51,360 $3.16 Million
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $3.55 Million - $4.1 Million	64,326	64,326 $4.14 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Account

Prospera Financial Services Inc Bristol Myers Squibb CO Transaction History